prazosin has been researched along with Cirrhosis, Liver in 6 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, PR | 1 |
| Rae, AP | 1 |
| Farah, DA | 1 |
| Russell, RI | 1 |
| Lorimer, AR | 1 |
| Carter, DC | 1 |
| Rubin, P | 1 |
| Blaschke, T | 1 |
| Albillos, A | 2 |
| Lledó, JL | 2 |
| Rossi, I | 2 |
| Pérez-Páramo, M | 1 |
| Tabuenca, MJ | 1 |
| Bañares, R | 2 |
| Iborra, J | 2 |
| Garrido, A | 2 |
| Escartín, P | 2 |
| Bosch, J | 2 |
| Calleja, JL | 1 |
| Lee, WC | 1 |
| Lin, HC | 1 |
| Yang, YY | 1 |
| Hou, MC | 1 |
| Lee, FY | 1 |
| Chang, FY | 1 |
| Lee, SD | 1 |
| Dubuisson, L | 1 |
| Desmoulière, A | 1 |
| Decourt, B | 1 |
| Evadé, L | 1 |
| Bedin, C | 1 |
| Boussarie, L | 1 |
| Barrier, L | 1 |
| Vidaud, M | 1 |
| Rosenbaum, J | 1 |
4 trials available for prazosin and Cirrhosis, Liver
| Article | Year |
|---|---|
Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension.
Topics: Atenolol; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hyperte | 1984 |
Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
Topics: Adrenergic alpha-Antagonists; Aldosterone; Blood Pressure; Female; Furosemide; Glomerular Filtration | 1995 |
Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
Topics: Adrenergic alpha-Antagonists; Female; Hemodynamics; Humans; Hypertension, Portal; Liver Cirrhosis; M | 1994 |
Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
Topics: Antihypertensive Agents; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension, Port | 2001 |
2 other studies available for prazosin and Cirrhosis, Liver
| Article | Year |
|---|---|
Prazosin protein binding in health and disease.
Topics: Adult; Blood Proteins; Erythrocytes; Female; Heart Failure; Humans; In Vitro Techniques; Kidney Fail | 1980 |
Inhibition of rat liver fibrogenesis through noradrenergic antagonism.
Topics: Adrenergic Agents; Adrenergic alpha-Antagonists; Animals; Carbon Tetrachloride; Liver; Liver Cirrhos | 2002 |